Moderna's stock price soared last week after the release of promising news about an experimental melanoma treatment using an mRNA-based cancer vaccine that the Cambridge company is working on with Merck. Two local cancer researchers explain how the treatment works and how it could mean for their field.
WBUR News
• WBUR
What does Moderna's melanoma treatment mean for cancer research? We asked 2 local experts